Financings in Brief: Weston Medical
This article was originally published in The Gray Sheet
Weston Medical: British company raises approximately $6.5 mil. to support continued development of its Intraject disposable, pre-filled needleless injector for delivery of liquid medicines. London-based Weston notes that Medeva plans to begin clinical trials using Intraject with their flu vaccine "shortly," and discussions are under way with "a number of other pharmaceutical companies" regarding "trials in other therapeutic areas"...
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.